Pre-eclampsia, a condition that causes dangerously high blood pressure, is a leading cause of death among mothers and babies.
Lack of OB/GYN care for hyperemesis gravidarum drives pregnant patients to IV spas offering treatment. Experts warn that ...
It's true that being pregnant with two comes with some risks, but with good prenatal care and close surveillance, they can be managed.
The human genome is riddled with relics of viral infections—bits of DNA from viruses that have been inserted in human DNA over millions of years and never left. Most are silent but some have taken on ...
DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for preeclampsia (PE), fetal growth restriction and acute ischemic stroke ...
An international team discovered that ancient viral DNA fragments help regulate genes essential for placental function. The study identified virus-derived enhancers linked to the gene EPS8L1, whose ...
Good morning, ladies and gentlemen, and welcome to the DiaMedica Therapeutics Q3, 2025 Earnings Conference Call. An audio recording of this webcast will be available shortly after the call today on ...
The 2025 Hamptons Doc Fest runs from December 4 to 11 at Sag Harbor Cinema, Bay Street Theater and Southampton Playhouse.
Detailed price information for Diamedica Therapeutics Inc (DMAC-Q) from The Globe and Mail including charting and trades.